Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

Hayete Gallot, a veteran Microsoft executive and current corporate vice president of its commercial solutions, will become ...